Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hou Jintong, Haslund-Gourley Benjamin, Diray-Arce Joann, Hoch Annmarie, Rouphael Nadine, Becker Patrice M, Augustine Alison D, Ozonoff Al, Guan Leying, Kleinstein Steven H, Peters Bjoern, Reed Elaine, Altman Matt, Langelier Charles R, Maecker Holden, Kim Seunghee, Montgomery Ruth R, Krammer Florian, Wilson Michael, Eckalbar Walter, Bosinger Steven E, Levy Ofer, Steen Hanno, Rosen Lindsey B, Baden Lindsey R, Melamed Esther, Ehrlich Lauren I R, McComsey Grace A, Sekaly Rafick P, Schaenman Joanna, Shaw Albert C, Hafler David A, Corry David B, Kheradmand Farrah, Atkinson Mark A, Brakenridge Scott C, Agudelo Higuita Nelson I, Metcalf Jordan P, Hough Catherine L, Messer William B, Pulendran Bali, Nadeau Kari C, Davis Mark M, Fernandez Sesma Ana, Simon Viviana, Kraft Monica, Bime Chris, Calfee Carolyn S, Erle David J, Impacc Network, Robinson Lucy F, Cairns Charles B, Haddad Elias K, Comunale Mary Ann
Аннотация
METHODS: We analyzed 1102 hospitalized COVID-19 participants. We used the lasso and forward selection to select top predictors for severity and mortality, and built predictive models based on balanced training data. We then validated the models on testing data.
RESULTS: Severity was best predicted by the baseline SpO2/FiO2 ratio obtained from COVID-19 patients (test AUC: 0.874). Adding patient age, BMI, FGF23, IL-6, and LTA to the disease severity prediction model improves the test AUC by an additional 3%. The clinical mortality prediction model using SpO2/FiO2 ratio, age, and BMI resulted in a test AUC of 0.83. Adding laboratory results such as TNFRSF11B and plasma ribitol count increased the prediction model by 3.5%. The severity and mortality prediction models developed outperform the Sequential Organ Failure Assessment (SOFA) score among inpatients and perform similarly to the SOFA score among ICU patients.
CONCLUSION: This study identifies clinical data and laboratory biomarkers of COVID-19 severity and mortality using machine learning models. The study identifies SpO2/FiO2 ratio to be the most important predictor for both severity and mortality. Several biomarkers were identified to modestly improve the predictions. The results also provide a baseline of SARS-CoV-2 infection during the early stages of the coronavirus emergence and can serve as a baseline for future studies that inform how the genetic evolution of the coronavirus affects the host response to new variants.